BVS Bioventus Inc. - 8-K

Item 5.07.    Submission of Matters to a Vote of Security Holders.

Bioventus, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) on June 3, 2026. A total of 75,279,174 shares (the “Shares”) of both Class A common stock and Class B common stock (collectively, the “Common Stock”) were present in person or represented by proxy at the 2026 Annual Meeting, representing approximately 90.23% of the outstanding Shares of Common Stock entitled to vote as a single class as of the April 6, 2026 record date.

The following proposals were voted upon at the 2026 Annual Meeting and the final voting results with respect to each such proposal are set forth below.

At the 2026 Annual Meeting, the stockholders elected the following directors to serve on the Company’s Board of Directors until the 2027 annual meeting of stockholders and until each such director’s respective successor is elected and qualified, or until each such director’s death, resignation or removal, based on the following votes:

Nominee

For

Withheld

Broker Non-Votes

William A. Hawkins

67,405,961

1,128,994

6,744,219

John A. Bartholdson

68,365,980

168,975

6,744,219

Patrick J. Beyer

68,062,114

472,841

6,744,219

Robert E. Claypoole

68,360,467

174,488

6,744,219

Philip G. Cowdy

67,748,512

786,443

6,744,219

Ajay Dhankhar

68,459,149

75,806

6,744,219

Mary Kay Ladone

67,160,936

1,374,019

6,744,219

Michelle McMurry-Heath

68,073,685

461,270

6,744,219

Guido J. Neels

68,049,659

485,296

6,744,219

Guy P. Nohra

67,767,651

767,304

6,744,219

Susan M. Stalnecker

68,060,987

473,968

6,744,219

Martin P. Sutter

61,710,650

6,824,305

6,744,219

The stockholders also ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The vote for such ratification was 75,228,481 Shares for, 5,021 Shares against, 45,672 Shares abstaining, and no broker non-votes.